BMY reiterated 2013 (first year post-Plavix) non-GAAP EPS guidance of $1.95+ that was first given in Mar 2010 (#msg-47502391). There is no official guidance for 2012.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”